Harry L. Leider, Chief Executive Officer at Organicell Regenerative Medicine, Inc. (OCEL), bought 1,049,450 shares at $0.10 ($60K) on 2023-06-28, disclosed to the SEC on 2023-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.10 | 549,450 | $55K | 91.7% |
| 2 | $0.01 | 500,000 | $5K | 8.3% |
| Total | $0.06 avg | 1,049,450 | $60K | 100% |
| Filing → |